The 'Global Registry of Acute Coronary Events' (GRACE) and the 'Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines' (CRUSADE) scores are among the most frequently used risk assessment tools. 2, 4, 5 GRACE was developed involving more than 40 000 patients presenting with ACS as a clinical risk prediction tool for estimating the cumulative 6-month risk of death and death or myocardial infarction to facilitate triage and management of patients with ACS. GRACE is not restricted to any ST segment alterations. 4 The CRUSADE-score was developed from a cohort of NSTEMI patients by Subherwal et al (2009) to estimate baseline risk of in-hospital major bleeding, and mortality and validated in more than 70 000 patients. 5 The GRACE and CRUSADE score have several similarities and tend to be used exchangeable in clinical practice ( Table 1) .
A recent study suggested superiority of the GRACE over the CRUSADE score to predict in-hospital mortality and major bleeding in a cohort of 1587 ACS patients. 6 Accordingly, it appears desirable to reappraise the comparison of these globally used scores.
| Importance
Cardiovascular diseases (CVD) are the number one cause of death globally. About 17.9 million people died from CVDs in 2016. It represented 31% of all global deaths, 85% of which occurred because of heart attack or stroke. These diseases lead to serious consequences such as disability or sudden death. As a result, there are high monetary costs related to the management of these diseases imposing a severe burden for the healthcare system. 7 Limited resources demand prudent and evidence based use of means, yet only one study compared these two scores. 6
| Goals of this investigation
We aimed to compare GRACE and CRUSADE risk scores to predict in-hospital mortality and major bleeding in patients, presenting to a high-volume academic emergency department, who were diagnosed with ACS.
| ME THODS

| Study design & setting
This is a cohort study in patients with the diagnosis of ACS according to ESC criteria 8 
| Methods and measurements
All eligible patients were prospectively enrolled in a registry according to the Cardiology Audit and Registration Data Standards (CARDS) of the European Society of Cardiology. 10 The registry contains demographics, cardiovascular risk factors, previous medical history, symptoms, vital parameters, ECG-and laboratory findings, previous and current medication, interventions, findings from coronary angiography and complications, including death. Both GRACE and CRUSADE risk scores were calculated individually from registry information.
| Outcomes
In-hospital mortality was retrieved from the hospital information system. Major bleeding was defined according to the CRUSADE definition. 5
| Analysis
We present categorical data as count and relative frequency, and metric data as mean ± standard deviation or median with What's known • Risk management is essential for the management of acute coronary syndrome.
• The GRACE and CRUSADE scores are amongst the most widely used tools to estimate risk of death or major bleeding.
What's new
• The GRACE score has good prediction capability for in-hospital death in patients with acute coronary syndrome, and is superior to CRUSADE.
• It is also better than CRUSADE to predict major bleeding, although the latter score was specifically developed for bleeding. were used for data analysis. A two-sided P-value of < .05 was generally considered statistically significant. Table 2 for details). Figure 1 for a comparison of risk distribution between scores).
TA B L E 1 GRACE and CRUSADE score parameters
| RE SULTS
| Characteristics of study subjects
| Main results
Overall risk classification differed significantly between GRACE and CRUSADE score (P < .001). This difference was mainly driven by the two lower risk categories (see Figure 1 ). 
| Discrimination
In-hospital mortality
For in-hospital death the AUC of the GRACE score was 0.91 (95% CI 0.89 to 0.93), and 0.83 (95% CI 0.80 to 0.86) for the CRUSADE Score, respectively. The AUCs differed significantly between the two scores (P < .01) (see Figure 2 ).
Major bleeding
The AUC for major bleeding was 0.71 (95% CI 0.65 to 0.76) for the GRACE score and 0.61 (95% CI 0.55 to 0.68) for the CRUSADE Score.
The AUCs differed significantly between the two scores (P < .01).
See Figure 3 . In line with the initial development populations, in our analysis, GRACE was superior to CRUSADE to predict mortality. In addition, although CRUSADE was primarily developed to assess risk of major bleeding, GRACE performed superior to CRUSADE for this outcome, too.
| D ISCUSS I ON
Our study adds to previous similar analysis, adding real-world data from a large tertiary care centre over a 10-year period. The proportion of patients with STEMI in our study is larger (54%) than in most other studies. This could be explained by the fact that our hospital serves as a tertiary care academic referral centre. On two of seven days a week, it provides the only cathlab service for a two mil- Bleeding complications are long known as an important outcome parameter in the management of ACS patients because of the fact they are associated with a worse outcome and higher costs. Therefore, various bleeding risk scores have been integrated to the daily clinical practice. Although most of them were developed from randomised clinical studies, and not by assessment of risk factors in large 'real world' cohorts. This might limit their generalisability to the general ACS population. 16, 17 Current guidelines recommend the use of the CRUSADE score for bleeding risk stratification. 8, 18, 19 In a cohort of 4500 ACS-patients, Abu-Assi et al found the CRUSADE to have highest accuracy to predict major bleeding com-
plications in STEMI and NSTE-ACS compared with ACTION-and
Mehran-bleeding risk scores, but did not compare it to the GRACE. 18 Amador et al first suggested that both ischaemic and bleeding risk scores could be used to predict in-hospital mortality, ischaemic events and death, reporting moderate discrimination for major bleeding and death for TIMI, GRACE and CRUSADE scores (c = 0.64, 0.58 and 0.61 for major bleeding, 0.92, 0.86 and 0.63 for death). 20 In the most recent analysis Manzano-Fernández investigated the use of a single score (either GRACE or CRUSADE) to predict both outcomes. They found better discrimination for GRACE compared with the CRUSADE risk score for mortality (0.86 vs 0.79; P = .018) and major bleeding (0.80 vs 0.73, P = .028). 6 These findings are supported by our results. This remains true although our study had a much longer study period (2 years vs 10 years), larger sample size, and we used a different statistical approach (logistic regression and c-statistics, vs the method by DeLong).
A possible explanation for the differences between Manzano-Fernandez's and our findings on the one hand, and the abovementioned studies might be the decreasing overall importance of bleeding complications in the era of primary PCI, compared with when thrombolysis still played a major role. This effect is further accentuated by the trend to increased use of radial, as compared with inguinal, punctuation approaches for PCI. The in-hospital mortality rate in our study was significantly lower than in the study by All our findings have to be regarded in context of some limitations: This was a single centre study, and findings might be less generalisable to non-tertiary care centres. It also has to be kept in mind that we performed a retrospective analysis, although of prospectively collected data following strict audit and registry standards. 10 In conclusion, the results of this study support previous findings on the superiority of the GRACE vs the CRUSADE score to predict in-hospital mortality in ACS patients, and adds to the growing evidence that this score might also serve the needs to predict bleeding complications. This single-score approach could ease clinical practice for all those involved in the initial management of ACS.
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